CALT Calliditas Therapeutics

USD 39.50 0.00 0
Icon

Calliditas Therapeutics (CALT) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Hold

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 39.50

0.00 (0.00)%

USD 1.05B

9.50K

USD 40.20(+1.77%)

USD 22.00 (-44.30%)

Icon

CALT

Calliditas Therapeutics (USD)
COMMON STOCK | NSD
USD 39.50
0.00 0
Take a Tour
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Hold

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 1.05B

USD 22.00 (-44.30%)

USD 39.50

Calliditas Therapeutics (CALT) Stock Forecast

Show ratings and price targets of :
USD 40.20
(+1.77%)

Based on the Calliditas Therapeutics stock forecast from 5 analysts, the average analyst target price for Calliditas Therapeutics is USD 40.20 over the next 12 months. Calliditas Therapeutics’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Calliditas Therapeutics is Slightly Bearish, which is based on 3 positive signals and 6 negative signals. At the last closing, Calliditas Therapeutics’s stock price was USD 39.50. Calliditas Therapeutics’s stock price has changed by +0.79% over the past week, +1.88% over the past month and +146.11% over the last year.

No recent analyst target price found for Calliditas Therapeutics
No recent average analyst rating found for Calliditas Therapeutics

Company Overview Calliditas Therapeutics

Calliditas Therapeutics AB (publ), a commercial-stage bio-pharmaceutical company, focused on identifying, developing, and commercializing novel treatments in orphan indications with an initial focus on renal and hepatic diseases with significant unmet medical needs in the United ...Read More

https://www.calliditas.se

Kungsbron 1, D5, Stockholm, Sweden, 111 22

219

December

USD

USA

Adjusted Closing Price for Calliditas Therapeutics (CALT)

Loading...

Unadjusted Closing Price for Calliditas Therapeutics (CALT)

Loading...

Share Trading Volume for Calliditas Therapeutics Shares

Loading...

Compare Performance of Calliditas Therapeutics Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CALT

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Calliditas Therapeutics (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD127.00B 31.94 20.00

ETFs Containing CALT

Symbol Name CALT's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Calliditas Therapeutics (CALT) Stock

Based on ratings from 5 analysts Calliditas Therapeutics's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 1 buy, sell and 4 hold ratings.

Unfortunately we do not have enough data on CALT's stock to indicate if its a good dividend stock.

Based on targets from 5 analysts, the average taret price for CALT is USD 40.20 over the next 12 months. The maximum analyst target price is USD 44 while the minimum anlayst target price is USD 39.

CALT stock's Price/Earning ratio is -99,999.99. Our analysis grades CALT stock's Price / Earning ratio at A+. This means that CALT stock's Price/Earning ratio is above 2.000000000000002% of the stocks in the Biotechnology sector in the NSD exchange. Based on this CALT may be undervalued for its sector.

The last closing price of CALT's stock was USD 39.50.

The most recent market capitalization for CALT is USD 1.05B.

Based on targets from 5 analysts, the average taret price for CALT is projected at USD 40.20 over the next 12 months. This means that CALT's stock price may go up by +1.77% over the next 12 months.

We can't find any ETFs which contains Calliditas Therapeutics's stock.

As per our most recent records Calliditas Therapeutics has 219 Employees.

Calliditas Therapeutics's registered address is Kungsbron 1, D5, Stockholm, Sweden, 111 22. You can get more information about it from Calliditas Therapeutics's website at https://www.calliditas.se.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...